Thursday, 09/03/2023 16:10

DCL: Approved the plan to issue shares under ESOP

    The Board resolution dated March 06, 2023, the BOD of Cuu Long Pharmaceutical Joint Stock Company approved to implement the plan for stock issuance under ESOP as follows:

-         Stock name: Cuu Long Pharmaceutical Joint Stock Company

-         Stock type: common share

-         Par value: 10,000 dongs/share

-         Charter capital: VND730,410,300,000

-         Number of outstanding shares: 73,041,030 shares

-         Number of shares expected to be issued: 2,000,000 shares

-         Total value of issue (at par value): VND20,000,000,000

-         Issue price: VND10,000/share

-         These shares will be restricted:

  • To the employees in the management team: in 01 year from the finish date of the issuance
  • To the employees in the Executive Board and the administration team: in 03 years from the finish date of the issuance

-         Estimated time of implementation: from March, 2023 to April, 2023, after being approved by the State Securities Commission of Vietnam (SSC).

 

HOSE

Other News

>   PSH: Capital contribution to establish a subsidiary (09/03/2023)

>   FIR: Increasing charter capital (09/03/2023)

>   CTD: Plan for stock issuance under ESOP 2023 (09/03/2023)

>   RAL: Report on the progress of using capital from the offering (07/03/2023)

>   PSH: Approval for the transfer of contributed capital of Dong Phu (07/03/2023)

>   ANV: Result of the ESOP (07/03/2023)

>   DPR: Issuance result of swap shares (07/03/2023)

>   TCD: Change of representative of contributed capital in Helios (07/03/2023)

>   KBC: Allow subsidiary to borrow capital (06/03/2023)

>   HAX: Increasing charter capital (06/03/2023)

Online Services
iDragon
Place Order

Là giải pháp giao dịch chứng khoán với nhiều tính năng ưu việt và tinh xảo trên nền công nghệ kỹ thuật cao; giao diện thân thiện, dễ sử dụng trên các thiết bị có kết nối Internet...
User manual
Updated version